Filing Details
- Accession Number:
- 0001911051-23-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-26 19:28:37
- Reporting Period:
- 2023-07-24
- Accepted Time:
- 2023-07-26 19:28:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 926617 | Aspira Women's Health Inc. | AWH | In Vitro & In Vivo Diagnostic Substances (2835) | 330595156 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1911051 | Rachelle Celeste Fralick | C/O Aspira Women'S Health Inc 12117 Bee Cave Rd Bldg 3-100 Austin TX 78738 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-24 | 754 | $3.98 | 12,032 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
